Free Health Updates
Skip to main content
Table of Contents
< All Topics
Print

How Does Cannabis Compare to Dopamine Agonists in Treating RLS? 

Posted
Updated
ByMy Patient Advice
Author: Dr. Clarissa Morton, PharmD

Dopamine agonists have long been a frontline treatment for Restless Legs Syndrome (RLS), with medications like pramipexole and ropinirole often prescribed to ease symptoms. But as interest in medical cannabis grows, many patients are now weighing the benefits of cannabis vs dopamine agonists for RLS treatment options. 

While dopamine agonists target the brain’s dopamine pathways to reduce leg discomfort and movement, they can come with side effects such as nausea, impulse control issues or augmentation, a worsening of symptoms over time. This has led many patients to explore how cannabis vs dopamine agonists in RLS therapies compare in terms of safety and long-term effectiveness. 

Can medical cannabis be accessed legally for women’s health?

Comparing Treatment Approaches 

Here’s how the two approaches differ in both function and impact: 

Mechanism and effectiveness 

Dopamine agonists work by mimicking the action of dopamine, a neurotransmitter involved in movement control. They are effective for many but not all. Cannabis, on the other hand, operates through the endocannabinoid system, potentially calming nerve activity and improving sleep. Early reports suggest comparable effectiveness in symptom relief for some patients, particularly when traditional medications fall short. 

Tolerability and long-term use 

One of the key differences between cannabis vs dopamine agonists in RLS therapy lies in tolerability. While both can be effective, cannabis is often considered better tolerated by some due to fewer long-term side effects, especially when used in carefully monitored, low-dose regimens. 

Both treatment paths have their place, and the best option depends on symptom severity, medical history and patient preference. 

Visit providers like LeafEase to explore how cannabis might serve as an alternative or complement to dopamine agonist therapy in your personalised RLS treatment plan. 

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to medical cannabis and Restless Legs Syndrome.

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories